|
Volumn 6, Issue 8, 2007, Pages 1251-1257
|
Extracellular matrix induces doxorubicin-resistance in human osteosarcoma cells by suppression of p53 function
|
Author keywords
Chemotherapy; DNA damage; Doxorubicin resistance; Extracellular matrix; Heparan sulfate proteoglycan; Osteosarcoma; p53
|
Indexed keywords
COLLAGEN TYPE 4;
DOXORUBICIN;
ENTACTIN;
FIBRONECTIN;
LAMININ;
PROTEIN P53;
PROTEOHEPARAN SULFATE;
ANTINEOPLASTIC ANTIBIOTIC;
DNA;
ADOLESCENT;
APOPTOSIS;
ARTICLE;
CANCER RESISTANCE;
CASE REPORT;
CELL CULTURE;
CELL PROLIFERATION;
CLINICAL ASSESSMENT;
CONTROLLED STUDY;
DNA DAMAGE;
EXTRACELLULAR MATRIX;
GENE MUTATION;
HUMAN;
HUMAN CELL;
MALE;
OSTEOSARCOMA CELL;
PROTEIN FUNCTION;
QUANTITATIVE ANALYSIS;
RELAPSE;
RISK ASSESSMENT;
BONE TUMOR;
CHEMISTRY;
DRUG EFFECT;
DRUG RESISTANCE;
GENETIC EPIGENESIS;
GENETICS;
METABOLISM;
OSTEOSARCOMA;
RADIOGRAPHY;
TUMOR CELL LINE;
ADOLESCENT;
ANTIBIOTICS, ANTINEOPLASTIC;
BONE NEOPLASMS;
CELL LINE, TUMOR;
DNA;
DNA DAMAGE;
DOXORUBICIN;
DRUG RESISTANCE, NEOPLASM;
EPIGENESIS, GENETIC;
EXTRACELLULAR MATRIX;
HUMANS;
MALE;
OSTEOSARCOMA;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 39749191991
PISSN: 15384047
EISSN: 15558576
Source Type: Journal
DOI: 10.4161/cbt.6.8.4443 Document Type: Article |
Times cited : (21)
|
References (30)
|